Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this crucial final discussion on the current scenario of cancer. The field of oncology is in the midst of a transformative era, driven by the profound importance of genomic testing and remarkable advancements in both diagnosis and treatment. In the past, cancer was often categorized by its anatomical location, leading to a "one-size-fits-all" approach. However, with the integration of cutting-edge technologies, we can now precisely identify the unique molecular and genetic drivers of each patient's tumor. This shift toward personalized medicine has enabled the development of highly effective targeted therapies and immunotherapies, which offer superior outcomes and fewer side effects compared to traditional cytotoxic chemotherapy.
The central pillar of this revolution is genomic testing, which provides a detailed blueprint of a tumor's genetic makeup. By identifying specific mutations, fusions, or other genomic alterations, clinicians can select treatments that directly target these abnormalities. This not only enhances therapeutic efficacy but also helps predict treatment resistance and informs clinical trial eligibility. Furthermore, advancements in diagnostic techniques, such as liquid biopsies and next-generation sequencing, are making it possible to detect cancer at earlier stages and monitor treatment response with unprecedented accuracy. This empowers healthcare providers to make more informed decisions, ensuring each patient receives the most appropriate and advanced care available.
Therefore, join Dr. Poonam Patil for this final discussion to gain a comprehensive understanding of how genomic testing is reshaping the current scenario of cancer care. Listen to the expert insights, grasp the shared knowledge on advancements in diagnosis and treatment, and continue to follow Hidoc for more such indispensable webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Unified Neuro/Psych Residency Program: New Proposal.
2.
Ignoring Colonoscopy Advice; Dry Mouth Acupuncture; Inflamed Tongue, Then Cancer.
3.
Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival
4.
AI is equally capable of reading breast cancer scans as human radiologists.
5.
Unlocking the potential of targeted therapies for multiple myeloma
1.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
2.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
3.
Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients
4.
AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined
5.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
4.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
5.
Navigating the Complexities of Ph Negative ALL - Part XVI
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation